In the present study, we aimed to gain a better understanding of the role of NDRG2 in the tumor microenvironment during the liver cancer metastasis process, hoping to find a new therapeutic target or prognostic biomarker for this life-threatening malignancy. The gene discussed is NDRG2; the disease is neoplasm.